Allient Inc

ALNT shows a clear medium-term downtrend marked by lower highs and lower lows since its July peak. Price is trading below the declining 9- and 20-day EMAs with continued follow-through selling and no signs of oversold exhaustion. Execution should be initiated now at the 50-day SMA and prior support zone as a continuation play.

• ↑Q2 2026 GAAP EPS $0.80 vs $0.61 est; revenue $153.8 M +10% YoY; net income $10.4 M +85% YoY.
• ↑Record order backlog drives FY26 EPS upgrade from $2.46 to $2.68.
• ↓Shares trade at ~$114 vs $66.66 intrinsic value, implying ~25% overvaluation and weak earnings yield.